DENTSPLY SIRONA (NASDAQ:XRAY) Stock Gets Downgrade from Zacks Research

Key Points

• Zacks Research downgraded DENTSPLY SIRONA from “hold” to “strong sell.” Across analysts, the stock has a consensus “Reduce” rating and an average price target of $12.42.
• Other firms also lowered price targets: Mizuho and Piper Sandler to $12, Barrington Research to $13, and BMO Capital Markets to $10.
• The company’s latest quarterly results missed estimates: earnings were $0.29 per share versus $0.31 expected, while revenue of $836 million fell 7.5% year over year and came in below forecasts.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) was downgraded by investment analysts at Zacks Research from a "hold" rating to a "strong sell" rating in a research note issued to investors on Monday, Zacks reports.

Several other research firms have also weighed in on XRAY. Mizuho reduced their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating for the company in a research report on Thursday, October 22nd. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an "outperform" rating on the stock in a report on Monday, October 26th. Piper Sandler dropped their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a "neutral" rating on the stock in a report on Friday, October 9th. BMO Capital Markets cut their target price on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating for the company in a research note on Thursday, September 17th. Finally, Bank of America restated a "buy" rating on shares of DENTSPLY SIRONA in a report on Friday. Three equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company's stock. According to MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of "Reduce" and a consensus target price of $12.42.

DENTSPLY SIRONA Stock Up 1.7%

XRAY opened at $9.70 on Monday. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.04 and a current ratio of 1.63. The company has a market capitalization of $1.92 billion, a PE ratio of -15.64, a P/E/G ratio of 1.36 and a beta of 0.87. The stock's fifty day moving average is $9.54 and its 200-day moving average is $11.25. DENTSPLY SIRONA has a one year low of $8.14 and a one year high of $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.31 by ($0.02). The firm had revenue of $836.00 million for the quarter, compared to the consensus estimate of $861.68 million. DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The company's quarterly revenue was down 7.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.37 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. On average, equities analysts predict that DENTSPLY SIRONA will post 1.24 EPS for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently bought and sold shares of XRAY. Edmond DE Rothschild Holding S.A. boosted its holdings in shares of DENTSPLY SIRONA by 1.4% in the third quarter. Edmond DE Rothschild Holding S.A. now owns 4,568,300 shares of the medical instruments supplier's stock worth $40,475,000 after buying an additional 65,000 shares during the period. Private Wealth Asset Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the third quarter valued at approximately $103,000. Heartland Advisors Inc. raised its holdings in shares of DENTSPLY SIRONA by 36.4% during the third quarter. Heartland Advisors Inc. now owns 1,591,750 shares of the medical instruments supplier's stock valued at $14,103,000 after acquiring an additional 424,400 shares during the period. Private Advisor Group LLC purchased a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $158,000. Finally, Ieq Capital LLC lifted its position in shares of DENTSPLY SIRONA by 50.7% in the 3rd quarter. Ieq Capital LLC now owns 265,945 shares of the medical instruments supplier's stock valued at $2,356,000 after acquiring an additional 89,429 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.